Program Description:
It is estimated that more than one third of men over age 45 suffer from hypogonadism (defined as a total testosterone level below 300 ng/ml). Perhaps even more disturbing to health care providers invested in men’s health is the fact that only 4%-5% of these men are receiving treatment for the condition. While hypogonadism may have a negative effect on quality of life and overall health, the unspoken question of how testosterone replacement may affect men who have been or will be diagnosed with prostate cancer looms in the background. The objective of this review is to better define the role that testosterone plays in the diagnosis, prognosis, and growth of prostate cancer and to review the current status of treatment for hypogonadism in the patient with prostate cancer.
Activity Objectives:
Upon completion of this educational activity, participants should be better able to:
- Review the current status of treatment for hypogonadism in the patient at risk for or diagnosed with prostate cancer.
- Define the role that testosterone plays in the diagnosis, prognosis, and growth of prostate cancer.
Target Audience: Urologists, nephrologists, primary care physicians, and other healthcare professionals who treat patients with hypogonadism and/or prostate cancer.
|
Credits
|
Type
|
Accreditation Statement
|
Designation Statement
|
|
1.00
|
AMA PRA Category 1 Credit(s)TM
|
This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of Medical Education Resources (MER) and Haymarket Media, Inc. MER is accredited by the ACCME to provide continuing medical education for physicians.
|
Medical Education Resources designates this educational activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)TM. Physicians should only claim credit commensurate with the extent of their participation in the activity.
|
Faculty:
Kelly Chiles, MD
Resident
Division of Urology
University of Connecticut Health Center, Farmington
Stanton Honig, MD
Associate Clinical Professor of Surgery
Division of Urology
University of Connecticut Health Center, Farmington
Disclosures:
DISCLOSURE OF CONFLICTS OF INTEREST
Medical Education Resources insures balance, independence, objectivity, and scientific rigor in all our educational programs. In accordance with this policy, MER identifies conflicts of interest with its instructors, content managers, and other individuals who are in a position to control the content of an activity. Conflicts are resolved by MER to ensure all scientific research referred to, reported, or used in a CME activity conforms to the generally accepted standards of experimental design, data collection, and analysis. MER is committed to providing its learners with high-quality CME activities that promote improvements or quality in health care and not the business interest of a commercial interest.
FACULTY DISCLOSURES
Stanton Honig, MD, has the following financial relationships to disclose: Auxilium, Coloplast, Endo, Serono, Slate Pharmaceuticals, Eli Lilly, Pfizer AMS
Kelly Chiles, MD, has nothing to disclose.
PUBLISHING STAFF DISCLOSURES
Jody A. Charnow and Marina Galanakis, Haymarket Media Group, have no financial relationship with any commercial interest.
Julie Johnson, PharmD, Medical Education Resources, Inc., has no financial relationship with any commercial interest.
DISCLOSURE OF UNLABELED USE
This educational activity may contain discussion of approved and/or investigational uses of agents that are not indicated by the FDA. Medical Education Resources, Inc. (MER), and Haymarket Medical Education (HME) do not recommend the use of any agent outside of the labeled indications.
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of MER and HME. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
DISCLAIMER
The content and views presented in this educational activity are those of the authors and do not necessarily reflect those of Medical Education Resources or Haymarket Media, Inc. The authors have disclosed if there is any discussion of published and/or investigational uses of agents that are not indicated by the FDA in their presentations. The opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of Medical Education Resources, or Haymarket Media, Inc. Before prescribing any medicine, primary references and full prescribing information should be consulted. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. The information presented in this activity is not meant to serve as a guideline for patient management.
Accredited Provider:
This program is sponsored by Medical Education Resources, Inc., and produced by Haymarket Medical Education.
If you have any questions relating to the accreditation of this activity, please contact:
Medical Education Resources, Inc.
1500 West Canal Court
Littleton, CO 80120-5615
Tel: 1-800-421-3756
E-mail:
info@mer.org
Instructions:
To obtain credit, a score of 70% or better is required. This CME is offered at no cost to participants. Please proceed with the activity until you have successfully completed this program, answered all test questions, completed the posttest survey, and have received a digital copy of your credit certificate. Your online certificate will be saved on myCME.com within your Profile/Exam History, which you can then access at any time.
To view the myCME privacy policy, please click here. To view the Medical Education Resources privacy policy, please click here.
SYSTEM REQUIREMENTS:
WINDOWS PC SYSTEM REQUIREMENTS:
266-MHz Pentium II; Windows 98 or higher; 64 MB RAM; 800 x 600 screen resolution
set for “High Color (16-Bit)”; Macromedia Flash Player 6 or higher.
MACINTOSH® SYSTEM REQUIREMENTS:
Power Mac g3 at 300 MHz; System 8.5 or higher (excluding Mac OSX); 96 MB RAM; 20
MB minimum hard disk space available; 800 x 600 screen resolution set to “Thousands
of Colors”; Macromedia Flash Player 6 or higher.